A federal judge scrutinizes Defense Secretary Pete Hegseth's testosterone initiative, questioning its alignment with transgender care policies for military personnel.
Washington DC, United States Jul 23, 2026 ALN: Defense Secretary Pete Hegseth’s new initiative to test and treat troops for low testosterone has prompted a federal judge to question the differences between that kind of testosterone replacement therapy and hormone treatment for transgender men in the military. This initiative, introduced as part of a broader effort to enhance the performance and health of military personnel, has raised significant legal and ethical questions regarding the treatment of transgender individuals within the armed forces.
U.S. District Judge Ana Reyes in Washington raised the question Wednesday in an ongoing lawsuit against President Donald Trump’s ban on transgender troops. The legal proceedings surrounding this ban have been complex and contentious, reflecting broader societal debates about gender identity, military service, and healthcare access. Reyes noted that Trump’s ban states, "the Armed Forces must adhere to high mental and physical health standards ... without the benefit of routine medical treatment or special provisions.” This statement has been a cornerstone of the arguments made by those supporting the ban, claiming it is necessary for maintaining military readiness and effectiveness.
Reyes ordered both parties in the lawsuit to address “the similarities and differences in administering TRT, both medically and logistically, for trans men compared to other service members, including cis individuals.” She was using the acronym for testosterone replacement therapy. This inquiry highlights the complexities involved in administering medical treatments within a diverse military population and raises questions about equity and access to healthcare resources.
The judge also requested information on the Pentagon’s “basis for treating trans men and other service members differently between this new policy and the Military Ban.” This request underscores the potential discrepancies in how different groups within the military are treated concerning their health care needs, particularly in light of evolving understandings of gender identity and medical care.
Reyes’ order comes a week after Hegseth announced that he is rolling out a new screening program for “testosterone deficiency” among troops, calling it necessary to allow them to operate at their “absolute best.” This initiative is part of a broader trend in military health care aimed at optimizing the performance of service members by addressing various health issues that may affect their capabilities.
The screenings will be conducted annually as part of service members’ required medical screenings for those 30 and older, he said. Troops under 30 can volunteer to be tested. In a video on social media, Hegseth stated that receiving testosterone replacement therapy would be voluntary. This voluntary aspect may reflect an attempt to balance the needs of service members with personal autonomy regarding their health care decisions.
Other Trump administration officials have begun to advocate for men to have easier access to testosterone replacement therapies, but the messaging from Hegseth and others blends known science on the hormone with broader, and less substantiated, claims. This blending of scientific understanding with anecdotal evidence raises concerns about the implications for medical practice and the potential for misinformed health policies.
Testosterone levels in men decline naturally with age and have long been linked to issues like erectile dysfunction, low libido, mood changes, and weight gain. However, experts have debated for years how to diagnose those problems and whether they should be treated by replacing the hormone. The medical community remains divided on the efficacy and necessity of testosterone replacement therapy, with some arguing that it is overprescribed and others advocating for its benefits in specific populations.
Reyes, who was nominated by President Joe Biden, is overseeing one of the lawsuits against Trump’s ban on transgender troops. The legal challenges to this ban have been numerous and varied, reflecting the ongoing struggle for transgender rights within the military context. Transgender active duty service members and former service members seeking to reenlist sued in late January 2025, shortly after the president returned for his second term in office, highlighting the urgency and importance of this issue for many individuals.
Reyes ruled last year against Trump’s executive order to exclude transgender troops, a decision that was seen as a significant victory for advocates of LGBTQ+ rights within the military. A divided panel of federal appeals court judges sent the case back to Reyes after partially upholding her order, finding that the ban was unlawful and service members who sued could not be kicked out. This legal back-and-forth illustrates the contentious nature of the debate surrounding military policy and gender identity.
Reyes has since given the case class-action status, which means the outcome could expand to all service members. This development could have far-reaching implications for the treatment of transgender individuals in the military, potentially affecting thousands of service members and their access to necessary medical care.
Trump’s transgender military ban remains in effect, however. The U.S. Supreme Court has allowed the Pentagon to enforce it as litigation plays out. This Supreme Court decision has been a source of frustration for many advocates who argue that the ban is discriminatory and harmful to both service members and military readiness. The ongoing legal battles reflect the broader societal divisions regarding transgender rights and the role of gender identity in public service.
The implications of Hegseth's testosterone policy, especially in light of the judge's questions, could set a precedent for how military health policies are developed and implemented. As the military grapples with issues of diversity and inclusion, the outcomes of these legal challenges will likely influence future policies regarding health care access for all service members, regardless of gender identity. The intersection of medical treatment, military policy, and individual rights will continue to be a critical area of focus as these issues evolve.
To learn more about the latest developments in Political Controversies, stay updated with our exclusive reports and analyses on AiLensNews.
